Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Oral compositions of MK2 pathway inhibitor for treatment of immune conditions

Oral compositions of MK2 pathway inhibitor for treatment of immune conditions

US Patent 12370195 · Granted Jul 29, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Deuterated MK2 pathway inhibitors and methods of using the same2025
Methods of synthesizing substituted pyridinone-pyridinyl compounds2025
Methods of synthesizing substituted pyridinone-pyridinyl compounds2025
Cancer treatments using combinations of CDK and ERK inhibitors2024
Anti-CD276 antibodies (B7H3)2023
Oral compositions of MK2 pathway inhibitor for treatment of immune conditions2023
Oral compositions of MK2 pathway inhibitor for treatment of immune conditions2023
Oral compositions of MK2 pathway inhibitor for treatment of immune conditions2023
Oral compositions of MK2 pathway inhibitor for treatment of immune conditions2023
Oral compositions of MK2 pathway inhibitor for treatment of immune conditions2023
Oral compositions of MK2 pathway inhibitor for treatment of immune conditions2023
Oral compositions of MK2 pathway inhibitor for treatment of immune conditions2023